Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -51.66%53.31M | ---- | 170.03%110.28M | ---- | -82.70%40.84M | ---- | -14.70%236.03M | ---- | 199.28%276.72M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 59.93%-1.64M | ---- | -72.04%-4.1M | ---- | -307.18%-2.38M | ---- | 77.69%-585K | ---- | 24.57%-2.62M |
| Dividend (income)- adjustment | ---- | ---- | ---- | 5.66%-50K | ---- | -381.82%-53K | ---- | 0.00%-11K | ---- | 94.12%-11K |
| Attributable subsidiary (profit) loss | ---- | 17.37%-154.84M | ---- | -56.84%-187.38M | ---- | 55.54%-119.47M | ---- | 15.23%-268.71M | ---- | -75.23%-317M |
| Impairment and provisions: | ---- | -13.07%15.91M | ---- | 84.11%18.3M | ---- | -92.27%9.94M | ---- | 56.67%128.58M | ---- | -26.75%82.07M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | 4,220.00%432K | ---- | 101.07%10K | ---- | -126.07%-933K |
| -Impairmen of inventory (reversal) | ---- | 617.17%1.9M | ---- | 59.89%-367K | ---- | 86.65%-915K | ---- | -843.80%-6.85M | ---- | -307.43%-726K |
| -Impairment of trade receivables (reversal) | ---- | 37.04%8.79M | ---- | 1,350.49%6.42M | ---- | -101.57%-513K | ---- | 2,769.68%32.66M | ---- | 296.21%1.14M |
| -Other impairments and provisions | ---- | -57.41%5.22M | ---- | 12.03%12.25M | ---- | -89.36%10.93M | ---- | 24.42%102.76M | ---- | -24.01%82.59M |
| Revaluation surplus: | ---- | -64.60%5.9M | ---- | -38.71%16.66M | ---- | 223.22%27.18M | ---- | -261.24%-22.05M | ---- | -34.92%13.68M |
| -Fair value of investment properties (increase) | ---- | -19.26%8.74M | ---- | -17.09%10.83M | ---- | 276.08%13.06M | ---- | -72.24%-7.42M | ---- | -289.81%-4.31M |
| -Other fair value changes | ---- | -148.76%-2.84M | ---- | -58.70%5.83M | ---- | 196.45%14.12M | ---- | -181.40%-14.64M | ---- | -4.09%17.98M |
| Asset sale loss (gain): | ---- | 68.00%-80K | ---- | 98.85%-250K | ---- | -1,623.87%-21.81M | ---- | 74.31%-1.27M | ---- | -20,416.67%-4.92M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 74.49%-1.26M | ---- | ---4.92M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 68.00%-80K | ---- | 98.85%-250K | ---- | -242,200.00%-21.81M | ---- | ---9K | ---- | ---- |
| Depreciation and amortization: | ---- | -5.23%1.78M | ---- | -37.41%1.87M | ---- | -14.06%2.99M | ---- | -4.73%3.48M | ---- | -23.40%3.66M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -73.68%5K | ---- | 0.00%19K |
| Financial expense | ---- | 40.19%4.26M | ---- | 559.00%3.04M | ---- | 429.89%461K | ---- | -91.04%87K | ---- | -74.20%971K |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.02%-101.69M | ---- | 19.58%-84.72M |
| Operating profit before the change of operating capital | ---- | -81.11%-75.41M | ---- | 33.18%-41.64M | ---- | -138.50%-62.31M | ---- | 18.82%-26.12M | ---- | 42.42%-32.18M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 87.73%-9.02M | ---- | -347.55%-73.48M | ---- | 772.76%29.68M | ---- | -108.21%-4.41M | ---- | 312.48%53.72M |
| Accounts receivable (increase)decrease | ---- | 84.46%-3.94M | ---- | -17,952.82%-25.35M | ---- | 101.61%142K | ---- | -121.15%-8.81M | ---- | 466.75%41.66M |
| Accounts payable increase (decrease) | ---- | -63.15%13.03M | ---- | 3,380.61%35.37M | ---- | ---1.08M | ---- | ---- | ---- | ---- |
| prepayments (increase)decrease | ---- | 42.68%14.32M | ---- | 161.84%10.04M | ---- | -196.24%-16.23M | ---- | 719.58%16.87M | ---- | -109.14%-2.72M |
| Financial assets at fair value (increase)decrease | ---11.41M | ---563K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 33.31%-24.27M |
| Special items for working capital changes | ---- | 133.29%484K | ---- | 91.23%-1.45M | ---- | 6.10%-16.59M | ---- | -201.49%-17.66M | ---- | 234.15%17.4M |
| Cash from business operations | ---11.41M | 37.29%-60.53M | ---- | -45.41%-96.51M | ---- | -65.34%-66.38M | ---- | -151.55%-40.14M | ---- | 202.86%77.87M |
| Other taxs | ---- | -320.13%-1.25M | ---- | 91.58%-298K | ---- | 49.02%-3.54M | ---- | -331.32%-6.94M | ---- | -460.63%-1.61M |
| Dividend received - operating | -12.50%40.79M | 25.00%78.67M | 185.71%46.62M | 2.86%62.94M | -53.33%16.32M | -34.37%61.19M | -25.00%34.97M | 14.29%93.24M | 33.33%46.62M | 16.67%81.59M |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.44%-41K | ---- | 0.00%-78K |
| Special items of business | 159.44%24.04M | --1.56M | 51.87%-40.45M | ---- | -132.59%-84.04M | ---- | -64.90%-36.13M | 120.33%32.31M | -133.59%-21.91M | -11.30%14.67M |
| Net cash from operations | 765.68%53.43M | 154.47%18.45M | 109.11%6.17M | -288.30%-33.88M | -5,707.98%-67.72M | -111.12%-8.72M | -104.72%-1.17M | -54.52%78.43M | -67.88%24.71M | 1,559.13%172.43M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 32.16%1.39M | -55.06%1.64M | -44.78%1.05M | 53.40%3.65M | 4,766.67%1.9M | 307.18%2.38M | 105.26%39K | -77.69%585K | -29.63%19K | -24.57%2.62M |
| Dividend received - investment | --48K | ---- | ---- | -5.66%50K | ---- | 381.82%53K | ---- | 0.00%11K | ---- | -94.12%11K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---19.43M | ---- | ---- |
| Sale of fixed assets | --150K | -68.00%80K | ---- | -98.91%250K | ---- | 255,066.67%22.97M | ---- | --9K | ---- | ---- |
| Purchase of fixed assets | -492.96%-421K | -81.71%-1.34M | -5.97%-71K | 92.28%-738K | 99.18%-67K | -1,132.60%-9.57M | -15,619.23%-8.17M | -319.46%-776K | 34.18%-52K | 94.57%-185K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 65.02%-546K | ---- | ---1.56M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --24.29M | --23.21M | ---- | ---- | ---- |
| Cash on investment | ---3.22M | 97.70%-415K | ---- | 33.05%-18.02M | -9.87%-17.67M | ---26.92M | -8,592.43%-16.08M | ---- | -116.30%-185K | 98.52%-500K |
| Net cash from investment operations | -310.24%-2.05M | 99.77%-34K | 106.17%977K | -212.20%-14.81M | -1,480.54%-15.84M | 165.52%13.2M | -359.63%-1M | -5,304.65%-20.14M | -120.13%-218K | 101.13%387K |
| Net cash before financing | 618.65%51.38M | 137.83%18.42M | 108.56%7.15M | -1,188.13%-48.68M | -3,754.15%-83.56M | -92.32%4.47M | -108.85%-2.17M | -66.27%58.29M | -68.61%24.49M | 828.49%172.82M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -107.09%-2.34M | -124.47%-4.15M | 6.32%33.02M | 34.38%16.95M | 2,507.67%31.06M | 96.36%12.61M | ---1.29M | 106.28%6.42M | ---- | -428.03%-102.3M |
| Interest paid - financing | ---- | -40.19%-4.26M | ---- | -559.00%-3.04M | ---- | -902.17%-461K | ---- | 94.85%-46K | ---- | 75.77%-893K |
| Dividends paid - financing | 50.00%-9.09M | -199.99%-27.26M | -99.99%-18.17M | 80.00%-9.09M | 75.00%-9.09M | -25.00%-45.43M | -33.33%-36.35M | -14.29%-36.35M | -20.00%-27.26M | -75.00%-31.8M |
| Other items of the financing business | 78.79%-678K | ---- | -105.20%-3.2M | ---- | -276.33%-1.56M | ---- | 15.34%-414K | ---- | 81.71%-489K | ---- |
| Net cash from financing operations | -203.90%-12.11M | -895.42%-35.79M | -42.92%11.65M | 113.25%4.5M | 153.65%20.41M | -9.95%-33.96M | -37.13%-38.05M | 77.59%-30.89M | 72.38%-27.75M | -2,133.19%-137.83M |
| Effect of rate | -82.53%112K | 98.69%-11K | 174.80%641K | 38.63%-842K | -272.43%-857K | -359.36%-1.37M | 306.22%497K | -66.11%529K | -138.38%-241K | 220.26%1.56M |
| Net Cash | 108.87%39.27M | 60.69%-17.37M | 129.77%18.8M | -49.85%-44.18M | -57.00%-63.14M | -207.61%-29.49M | -1,134.47%-40.22M | -21.69%27.4M | 85.48%-3.26M | 306.50%34.99M |
| Begining period cash | -22.76%58.97M | -37.10%76.35M | -37.10%76.35M | -20.27%121.37M | -20.27%121.37M | 22.47%152.23M | 22.47%152.23M | 41.65%124.3M | 41.65%124.3M | -17.21%87.75M |
| Cash at the end | 2.67%98.35M | -22.76%58.97M | 66.96%95.79M | -37.10%76.35M | -49.01%57.37M | -20.27%121.37M | -6.87%112.51M | 22.47%152.23M | 83.20%120.8M | 41.65%124.3M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.